The Effectiveness and Safety of Dupilumab in Children with Asthma in China: a Real-world Study
- Status
- ENROLLING_BY_INVITATION
- Phase
- N/A
Clinical Trials Related to Dupilumab
Related studies linked through entity extraction aliases.
Dupixent Study for Alternate Administration
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
Phase I/II Study of Neoadjuvant Cemiplimab and Dupilumab in Early-Stage Non-Small Cell Lung Cancer
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Dupilumab Versus Topical Corticosteroid Effectiveness - Comparison in the Treatment of Stenotic EoE
- Status
- RECRUITING
- Phase
- PHASE2
A Non-interventional Observational Study to Assess Long-term Efficacy and Safety of Dupilumab for the Treatment of Patients (>= 12 Years) With Eosinophilic Esophagitis Under Real-world-conditions in Germany
- Status
- RECRUITING
- Phase
- N/A
A U.S. Registry of Eosinophilic Esophagitis Pediatric, Adolescent and Adult Patients Treated With DUPIXENT® As Standard of Care
- Status
- RECRUITING
- Phase
- N/A
A Study to Investigate Improvement in Pruritus of Lichen Simplex Chronicus With Dupilumab Injections Compared With Placebo in Male and Female Participants Aged at Least 18 Years (STYLE 2)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study to Investigate Improvement in Pruritus of Lichen Simplex Chronicus With Dupilumab Injections Compared With Placebo in Male and Female Participants Aged at Least 18 Years (STYLE 1)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Real-life Evaluation of the Efficacy of Biologicals in Chronic Rhinosinusitis With Nasal Polyposis (CRSwNP)
- Status
- RECRUITING
- Phase
- N/A
Neoadjuvant Dupilumab, Pembrolizumab, Paclitaxel, and Carboplatin in Locally Advanced Triple Negative Breast Cancer
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
Expanded Access of Dupilumab in Adults With Severe Immunoglobulin E (EgE)-Mediated Food Allergy Previously Treated With Linvoseltamab
- Status
- TEMPORARILY_NOT_AVAILABLE
- Phase
- N/A
Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/LABA) in Comparison to ICS Dose Escalation to High Dose ICS/LABA in Adolescent and Adult Patients With Uncontrolled Asthma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE4
Immunologic Impact of Dupilumab in Patients Suffering From Asthma and Chronic Rhinosinusitis With Polyps
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
Dupilumab and House Dust Mite Immunotherapy in Patients With Atopic Dermatitis
- Status
- COMPLETED
- Phase
- NA
Dupilumab as Add-On Therapy for Hypereosinophilic Syndrome With Partial Clinical Response to Eosinophil-Depleting Biologic Agents
- Status
- RECRUITING
- Phase
- PHASE2
Efficacy and Safety of Dupilumab in Combination With Tofacitinib in Moderate to Severe Adult AD Patients
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE4
Study of Dupilumab 300 mg Every Other Week After Endoscopic Sinus Surgery in Patients With Allergic Fungal Rhinosinusitis (AFRS) on a Background Therapy With Intranasal Corticosteroid Spray
- Status
- WITHDRAWN
- Phase
- PHASE3
A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
- Status
- RECRUITING
- Phase
- PHASE3
Study in Paediatric Patients With Atopic Dermatitis Treated With Dupilumab in Spain
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Study in Adults With Severe Chronic Rhinosinusitis With Nasal Polyposis Treated With Dupilumab in France
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A